Evidence map›Paper›PMID 31028084›Full record

ArticleThe EMBO journal2019

Triggering MSR1 promotes JNK-mediated inflammation in IL-4-activated macrophages.

Manman Guo, Anetta Härtlova, Marek Gierliński, Alan Prescott, Josep Castellvi, Javier Hernandez Losa, Sine K Petersen, Ulf A Wenzel, Brian D Dill, Christoph H Emmerich and 3 more

Open access · hybridAbstract read
In one paragraph

Article in The EMBO journal, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 64 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
64citing papers in PubMed, 1 pooled it
4.5field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

64 citing papers in PubMed, 1 synthesis or guideline pooled it, 100 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Liver Macrophage Diversity in Health and Disease.Results and problems in cell differentiation · 2024
    Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article

4 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 4 countries.

Manman GuoMRC Protein Phosphorylation and Ubiquitylation Unit, University of Dundee, Dundee, UK.ORCID 0000-0002-7928-8902
Anetta HärtlovaMRC Protein Phosphorylation and Ubiquitylation Unit, University of Dundee, Dundee, UK anetta.hartlova@gu.se matthias.trost@ncl.ac.uk.ORCID 0000-0002-8152-4361
Marek GierlińskiData Analysis Group, School of Life Sciences, University of Dundee, Dundee, UK.
Alan PrescottDivision of Cell Signalling and Immunology, School of Life Sciences, University of Dundee, Dundee, UK.
Josep CastellviDepartment of Pathology, Hospital Universitario Vall d'Hebron, Barcelona, Spain.
Javier Hernandez LosaDepartment of Pathology, Hospital Universitario Vall d'Hebron, Barcelona, Spain.
Sine K PetersenWallenberg Centre for Molecular and Translational Medicine, University of Gothenburg, Gothenburg, Sweden.
Ulf A WenzelWallenberg Centre for Molecular and Translational Medicine, University of Gothenburg, Gothenburg, Sweden.
Brian D DillMRC Protein Phosphorylation and Ubiquitylation Unit, University of Dundee, Dundee, UK.
Christoph H EmmerichMRC Protein Phosphorylation and Ubiquitylation Unit, University of Dundee, Dundee, UK.
Santiago Ramon Y CajalDepartment of Pathology, Hospital Universitario Vall d'Hebron, Barcelona, Spain.
David G RussellDepartment of Microbiology and Immunology, College of Veterinary Medicine, Cornell University, Ithaca, NY, USA.
Matthias TrostMRC Protein Phosphorylation and Ubiquitylation Unit, University of Dundee, Dundee, UK anetta.hartlova@gu.se matthias.trost@ncl.ac.uk.ORCID 0000-0002-5732-700X
University of Dundee · GBVall d'Hebron Hospital Universitari · ESUniversity of Gothenburg · SECornell University · US

Funding

Medical Research Council MC_UP_A500_1020Medical Research Council MC_UU_12016/5Medical Research Council MR/K015869/1Wellcome Trust
6 · The paper itself

Abstract

Alternatively activated M2 macrophages play an important role in maintenance of tissue homeostasis by scavenging dead cells, cell debris and lipoprotein aggregates via phagocytosis. Using proteomics, we investigated how alternative activation, driven by IL-4, modulated the phagosomal proteome to control macrophage function. Our data indicate that alternative activation enhances homeostatic functions such as proteolysis, lipolysis and nutrient transport. Intriguingly, we identified the enhanced recruitment of the TAK1/MKK7/JNK signalling complex to phagosomes of IL-4-activated macrophages. The recruitment of this signalling complex was mediated through K63 polyubiquitylation of the macrophage scavenger receptor 1 (MSR1). Triggering of MSR1 in IL-4-activated macrophages leads to enhanced JNK activation, thereby promoting a phenotypic switch from an anti-inflammatory to a pro-inflammatory state, which was abolished upon MSR1 deletion or JNK inhibition. Moreover, MSR1 K63 polyubiquitylation correlated with the activation of JNK signalling in ovarian cancer tissue from human patients, suggesting that it may be relevant for macrophage phenotypic shift

Indexed as

InflammationMacrophage ActivationAnimalsCell PolarityCells, CulturedFemaleHumansInflammation MediatorsInterleukin-4JNK Mitogen-Activated Protein KinasesLipolysisLipoproteins, LDLMacrophagesMiceMice, Inbred C57BLMice, KnockoutfucoidanInflammation MediatorsInterleukin-4JNK Mitogen-Activated Protein KinasesLipoproteins, LDLMSR1 protein, humanoxidized low density lipoproteinPolysaccharidesScavenger Receptors, Class Amacrophage scavenger receptor 1phagosomeproteomicsscavenger receptortumour‐associated macrophages

Identifiers

PMID31028084
PMCPMC6545745
OpenAlexW2885509002

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.